CME Session
Hybrid Session
Daniel YC Heng, MD
Tom Baker Cancer Centre, Calgary, AB, Canada, United States
Disclosure: Disclosure(s): Non-CE Consulting: Eisai (Ongoing); Ipsen (Ongoing); Merck (Ongoing); Novartis (Ongoing); Pfizer (Ongoing)